ASHI 2026 has ended. This guide stays up as the record of who was there. Next: ASHI 2027, Sep 13–17, 2027 in New Orleans
University of Michigan at ASHI 2026
Oct 26–30, 2026 Montréal, Canada ~1k attendees Website
University of Michigan takes part in 3 sessions at ASHI 2026 in Montréal. Its work spans biomarkers of antibody injury and response to plasma cell-targeted therapy after heart transplantation, and a novel HLA-A*74 variant whose MFI values suggest apparent self-reactivity. It also argues that software interpretation of KIR centromeric and telomeric haplotypes cuts the errors of manual calls.
| Organization | ASHI 2026 Attendance |
|---|---|
University of Michigan Ann Arbor, MI | |
Public research university with a medical school and Michigan Medicine, an academic health system with organ transplant programs. | Poster Integrated Biomarkers Reveal Coordinated Biologic States of Humoral Injury and Response to Plasma Cell-Targeted Therapy After Heart Transplantation Solid organ transplantationChimerism, cell-free DNA and post-transplant monitoring Poster When MFI Misleads: Allele-level discordance reveals apparent self-reactivity in a novel HLA-A*74 variant HLA antibodies, crossmatching and epletsHLA typing, sequencing and genotyping Poster Utilizing Software Interpretation of the KIR Cen-/Tel- Haplotypes is Expected to Reduce the Error Rates Seen with Manually Performed Interpretations. HLA typing, sequencing and genotypingBioinformatics, AI and risk modeling |
Find decision makers at University of Michigan
Tell us what you sell and we’ll find the people at University of Michigan most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society for Histocompatibility and Immunogenetics (ASHI). Submit a correction